Abiopharma

🔍 Cappotelli Andrew (Executive)

Company: Paylocity Holding Corp (PCTY)

Report Date: 2026-08-19

Detailed Transactions and Holdings:

• Sold 145 shares of Common Stock, par value $0.001 at $147.6 per share (Direct)
  Date: 2026-08-19 | Code: S | equity_swap_involved: 0 | shares_owned_after: 46,734.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 1,358 shares of Common Stock, par value $0.001 at $149.58 per share (Direct)
  Date: 2026-08-19 | Code: S | equity_swap_involved: 0 | shares_owned_after: 45,376.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 802 shares of Common Stock, par value $0.001 at $150.3 per share (Direct)
  Date: 2026-08-19 | Code: S | equity_swap_involved: 0 | shares_owned_after: 44,574.00 | transaction_form_type: 4 | Footnotes: F1, F3
• Sold 245 shares of Common Stock, par value $0.001 at $150.99 per share (Direct)
  Date: 2026-08-19 | Code: S | equity_swap_involved: 0 | shares_owned_after: 44,329.00 | transaction_form_type: 4 | Footnotes: F1, F4

Footnotes:

• F1: The transaction indicated was conducted under an approved 10b5-1 Plan adopted by the reporting person on August 27, 2025.
• F2: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $148.93 to $149.90, inclusive. The reporting person undertakes to provide to Paylocity Holding Corporation, any security holder of Paylocity Holding Corporation, or the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes 2, 3 and 4 of this Form 4.
• F3: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $149.96 to $150.93, inclusive.
• F4: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $150.97 to $150.99, inclusive.